Margaret Haney, PH.D.
Professor of Clinical Neurobiology (in Psychiatry)
Director of Marijuana Research Laboratory,
New York State Psychiatric Institute
Associate Director of the Substance Use Research Center,
Dr. Margaret (Meg) Haney is a Professor of Clinical Neurobiology, and Co-Director of the Substance Use Research Center at Columbia University. Her research focuses on the consequences of chronic marijuana use, as well as the development of novel approaches for the treatment of cocaine and marijuana dependence. She and her colleagues were one of the first to demonstrate that marijuana produces a time-dependent, pharmacologically-specific withdrawal syndrome . An additional interest is the potential therapeutic effects of marijuana and other cannabinoids. Dr. Haney is an author of more than 110 articles in peer-reviewed journals, acts as an advisory editor for Psychopharmacology, and has been a member of NIH review groups.
Undergraduate: Rutgers College, B.S., 1981-1985
Graduate: Tufts University, M.A., Ph.D., 1985-1992
• Drug Dependence
I am interested in characterizing and developing treatments for marijuana dependence as well as cocaine dependence.
1. Haney M, Bedi G, Cooper ZD, Glass A, Vosburg SK, Comer SD, Foltin RW: Predictors of Marijuana Relapse in the Human Laboratory: Robust Impact of Tobacco Cigarette
Smoking Status. Biological Psychiatry in press
2. Haney M, Gunderson EW, Jiang H, Collins ED, Foltin RW: Cocaine-specific antibodies blunt the subjective effects of smoked cocaine in humans. Biological Psychiatry 2010;67: 59-65
3. Haney M, Spealman R: Controversies in translational research: Drug self-administration, Invited Review. Psychopharmacology 2008;199: 403-419
4. Haney M: Neurobiology of Stimulants, M Galanter, HD Kleber (Eds.), Textbook of Substance Abuse: 4th Edition., Washington, DC, USA, 2008
5. Haney M, Gunderson EW, Rabkin J, Hart CL, Vosburg SK, Comer SD, Foltin RW: Dronabinol and marijuana in HIV+ marijuana smokers: Caloric intake, mood and sleep. JAIDS 2007;32: 1391-1403